Id | Health state | Japanese DW | GBD 2013 DW [11] | Factor of two or greater difference | Factor of three or greater difference |
---|---|---|---|---|---|
Infectious disease | |||||
1 | Infectious disease, acute episode, mild | 0.012 (0.005–0.022) | 0.006 (0.002–0.012) | ||
2 | Infectious disease, acute episode, moderate | 0.424 (0.289–0.577) | 0.051 (0.032–0.074) | Japan > GBD | Japan > GBD |
3 | Infectious disease, acute episode, severe | 0.242 (0.163–0.340) | 0.133 (0.088–0.190) | ||
4 | Infectious disease, post-acute consequences (fatigue, emotional lability, insomnia) | 0.074 (0.047–0.106) | 0.219 (0.148–0.308) | Japan < GBD | |
5 | Diarrhea, mild | 0.119 (0.079–0.165) | 0.074 (0.049–0.104) | ||
6 | Diarrhea, moderate | 0.250 (0.170–0.345) | 0.188 (0.125–0.264) | ||
7 | Diarrhea, severe | 0.387 (0.263–0.517) | 0.247 (0.164–0.348) | ||
8 | Epididymo-orchitis | 0.204 (0.139–0.283) | 0.128 (0.086–0.180) | ||
9 | Herpes zoster | 0.181 (0.123–0.257) | 0.058 (0.035–0.090) | Japan > GBD | Japan > GBD |
10 | HIV cases, symptomatic, pre-AIDS | 0.200 (0.140–0.275) | 0.274 (0.184–0.377) | ||
11 | HIV/AIDS cases, receiving ARV treatment | 0.155 (0.108–0.219) | 0.078 (0.052–0.111) | ||
12 | AIDS cases, not receiving ARV treatment | 0.394 (0.268–0.527) | 0.582 (0.406–0.743) | ||
13 | Ear pain | 0.058 (0.037–0.085) | 0.013 (0.007–0.024) | Japan > GBD | Japan > GBD |
14 | Tuberculosis, HIV infected | 0.267 (0.181–0.372) | 0.408 (0.274–0.549) | ||
15 | Tuberculosis, not HIV infected | 0.254 (0.175–0.348) | 0.333 (0.224–0.454) | ||
Cancer | |||||
16 | Cancer, diagnosis and primary therapy | 0.174 (0.121–0.243) | 0.288 (0.193–0.399) | ||
17 | Cancer, metastatic | 0.230 (0.158–0.312) | 0.451 (0.307–0.600) | ||
18 | Cancer, after treatment | 0.079 (0.052–0.115) | NA | ||
19 | Mastectomy | 0.075 (0.047–0.108) | 0.036 (0.020–0.057) | Japan > GBD | |
20 | Stoma | 0.146 (0.099–0.200) | 0.095 (0.063–0.131) | ||
21 | Terminal phase, with medication (for cancers, end-stage kidney/liver disease) | 0.589 (0.425–0.743) | 0.540 (0.377–0.687) | ||
22 | Terminal phase, without medication (for cancers, end-stage kidney/liver disease) | 0.537 (0.378–0.693) | 0.569 (0.389–0.727) | ||
Cardiovascular and circulatory disease | |||||
23 | Acute myocardial infarction: days 1-2 | 0.253 (0.173–0.353) | 0.432 (0.288–0.579) | ||
24 | Acute myocardial infarction, days 3-28 | 0.032 (0.019–0.050) | 0.074 (0.049–0.105) | Japan < GBD | |
25 | Angina pectoris, mild | 0.019 (0.010–0.033) | 0.033 (0.020–0.052) | ||
26 | Angina pectoris, moderate | 0.040 (0.024–0.062) | 0.080 (0.052–0.133) | ||
27 | Angina pectoris, severe | 0.163 (0.111–0.227) | 0.167 (0.110–0.240) | ||
28 | Cardiac conduction disorders and cardiac dysrhythmias | 0.426 (0.297–0.561) | 0.224 (0.151–0.312) | ||
29 | Claudication | 0.020 (0.011–0.034) | 0.014 (0.007–0.025) | ||
30 | Heart failure, mild | 0.016 (0.008–0.028) | 0.041 (0.026–0.062) | Japan < GBD | |
31 | Heart failure, moderate | 0.041 (0.025–0.061) | 0.072 (0.047–0.103) | ||
32 | Heart failure, severe | 0.240 (0.166–0.336) | 0.179 (0.122–0.251) | ||
33 | Stroke: long-term consequences, mild | 0.019 (0.010–0.033) | 0.019 (0.010–0.032) | ||
34 | Stroke: long-term consequences, moderate | 0.044 (0.027–0.067) | 0.070 (0.046–0.099) | ||
35 | Stroke: long-term consequences, moderate plus cognition problems | 0.108 (0.074–0.150) | 0.316 (0.206–0.437) | Japan < GBD | |
36 | Stroke: long-term consequences, severe | 0.550 (0.386–0.701) | 0.552 (0.377–0.707) | ||
37 | Stroke: long-term consequences, severe plus cognition problems | 0.579 (0.411–0.732) | 0.588 (0.411–0.744) | ||
Diabetes and digestive and genitourinary disease | |||||
38 | Diabetic foot | 0.064 (0.041–0.093) | 0.020 (0.010–0.034) | Japan > GBD | Japan > GBD |
39 | Diabetic neuropathy | 0.098 (0.063–0.136) | 0.133 (0.089–0.187) | ||
40 | Chronic kidney disease (stage IV) | 0.106 (0.070–0.151) | 0.104 (0.070–0.147) | ||
41 | End-stage renal disease, on dialysis | 0.278 (0.189–0.382) | 0.571 (0.398–0.725) | Japan < GBD | |
42 | End-stage renal disease, with kidney transplant | 0.018 (0.010–0.032) | 0.024 (0.014–0.039) | ||
43 | Decompensated cirrhosis of the liver | 0.101 (0.067–0.144) | 0.178 (0.123–0.250) | ||
44 | Gastric bleeding | 0.541 (0.387–0.690) | 0.325 (0.209–0.462) | ||
45 | Crohn’s disease or ulcerative colitis | 0.219 (0.152–0.308) | 0.231 (0.156–0.320) | ||
46 | Benign prostatic hypertrophy: symptomatic | 0.096 (0.064–0.136) | 0.067 (0.043–0.097) | ||
47 | Urinary incontinence | 0.210 (0.143–0.292) | 0.139 (0.094–0.198) | ||
48 | Stress incontinence | 0.014 (0.007–0.026) | 0.020 (0.011–0.035) | ||
49 | Impotence | 0.017 (0.009–0.030) | 0.017 (0.009–0.030) | ||
50 | Infertility, primary | 0.009 (0.004–0.018) | 0.008 (0.003–0.015) | ||
51 | Infertility, secondary | 0.008 (0.003–0.016) | 0.005 (0.002–0.011) | ||
Chronic respiratory disease | |||||
52 | Asthma, controlled | 0.006 (0.003–0.013) | 0.015 (0.007–0.026) | Japan < GBD | |
53 | Asthma, partially controlled | 0.044 (0.027–0.065) | 0.036 (0.022–0.055) | ||
54 | Asthma: uncontrolled | 0.212 (0.145–0.294) | 0.133 (0.086–0.192) | ||
55 | COPD and other chronic respiratory problems, mild | 0.008 (0.003–0.016) | 0.019 (0.007–0.026) | Japan < GBD | |
56 | COPD and other chronic respiratory problems, moderate | 0.232 (0.158–0.319) | 0.225 (0.153–0.310) | ||
57 | COPD and other chronic respiratory problems, severe | 0.299 (0.203–0.405) | 0.408 (0.273–0.556) | ||
Neurological disorders | |||||
58 | Dementia, mild | 0.037 (0.022–0.056) | 0.069 (0.046–0.099) | ||
59 | Dementia, moderate | 0.382 (0.263–0.519) | 0.377 (0.252–0.508) | ||
60 | Dementia, severe | 0.511 (0.358–0.657) | 0.449 (0.304–0.595) | ||
61 | Headache: migraine | 0.518 (0.365–0.668) | 0.441 (0.294–0.588) | ||
62 | Headache: tension-type | 0.109 (0.074–0.153) | 0.037 (0.022–0.057) | Japan > GBD | |
63 | Headache: medication overuse | 0.185 (0.129–0.262) | 0.223 (0.146–0.313) | ||
64 | Multiple sclerosis, mild | 0.235 (0.160–0.324) | 0.183 (0.124–0.253) | ||
65 | Multiple sclerosis, moderate | 0.467 (0.325–0.615) | 0.463 (0.313–0.613) | ||
66 | Multiple sclerosis, severe | 0.653 (0.483–0.798) | 0.719 (0.534–0.858) | ||
67 | Epilepsy, seizures ≥ once a month | 0.533 (0.373–0.686) | 0.552 (0.375–0.710) | ||
68 | Epilepsy, seizures < once a month | 0.396 (0.273–0.525) | 0.263 (0.173–0.367) | ||
69 | Parkinson’s disease, mild | 0.016 (0.008–0.028) | 0.010 (0.005–0.019) | ||
70 | Parkinson’s disease, moderate | 0.193 (0.133–0.269) | 0.267 (0.181–0.372) | ||
71 | Parkinson’s disease, severe | 0.527 (0.372–0.681) | 0.575 (0.396–0.730) | ||
Mental, behavioral, and substance use disorders | |||||
72 | Alcohol use disorder, very mild | 0.064 (0.040–0.092) | 0.123 (0.082–0.177) | ||
73 | Alcohol use disorder, mild | 0.219 (0.151–0.306) | 0.235 (0.160–0.327) | ||
74 | Alcohol use disorder, moderate | 0.312 (0.213–0.422) | 0.373 (0.248–0.508) | ||
75 | Alcohol use disorder, severe | 0.413 (0.282–0.551) | 0.570 (0.396–0.732) | ||
76 | Drug dependence, mild | 0.330 (0.229–0.446) | NA | ||
77 | Drug dependence | 0.581 (0.419–0.740) | NA | ||
78 | Anxiety disorders, mild | 0.014 (0.007–0.026) | 0.030 (0.018–0.046) | Japan < GBD | |
79 | Anxiety disorders, moderate | 0.108 (0.072–0.150) | 0.133 (0.091–0.186) | ||
80 | Anxiety disorders, severe | 0.376 (0.258–0.509) | 0.523 (0.362–0.677) | ||
81 | Major depressive disorder, mild episode | 0.060 (0.038–0.088) | 0.145 (0.099–0.209) | Japan < GBD | |
82 | Major depressive disorder, moderate episode | 0.302 (0.204–0.410) | 0.396 (0.267–0.531) | ||
83 | Major depressive disorder, severe episode | 0.533 (0.378–0.680) | 0.658 (0.477–0.807) | ||
84 | Bipolar disorder: manic episode | 0.321 (0.220–0.439) | 0.492 (0.341–0.646) | ||
85 | Bipolar disorder: residual state | 0.031 (0.017–0.048) | 0.032 (0.018–0.051) | ||
86 | Schizophrenia: acute state | 0.575 (0.408–0.733) | 0.778 (0.606–0.900) | ||
87 | Schizophrenia: residual state | 0.412 (0.283–0.554) | 0.588 (0.411–0.754) | ||
88 | Anorexia nervosa | 0.196 (0.137–0.272) | 0.224 (0.150–0.312) | ||
89 | Bulimia nervosa | 0.280 (0.191–0.378) | 0.223 (0.150–0.312) | ||
90 | Attention deficit hyperactivity disorder | 0.052 (0.032–0.076) | 0.045 (0.028–0.066) | ||
91 | Conduct disorder | 0.243 (0.167–0.332) | 0.241 (0.159–0.341) | ||
92 | Asperger’s syndrome | 0.099 (0.065–0.142) | 0.104 (0.071–0.147) | ||
93 | Autism | 0.176 (0.122–0.245) | 0.262 (0.176–0.365) | ||
94 | Intellectual disability, borderline | 0.014 (0.006–0.024) | 0.011 (0.005–0.020) | ||
95 | Intellectual disability, mild | 0.047 (0.030–0.071) | 0.043 (0.026–0.064) | ||
96 | Intellectual disability, moderate | 0.074 (0.047–0.108) | 0.100 (0.066–0.142) | ||
97 | Intellectual disability, severe | 0.122 (0.083–0.172) | 0.160 (0.107–0.266) | ||
98 | Intellectual disability, profound | 0.230 (0.159–0.317) | 0.200 (0.133–0.283) | ||
Hearing and vision loss | |||||
99 | Hearing loss, mild | 0.027 (0.015–0.044) | 0.010 (0.004–0.019) | Japan > GBD | |
100 | Hearing loss, moderate | 0.038 (0.023–0.057) | 0.027 (0.015–0.042) | ||
101 | Hearing loss, severe | 0.208 (0.143–0.294) | 0.158 (0.105–0.227) | ||
102 | Hearing loss, profound | 0.241 (0.167–0.338) | 0.204 (0.134–0.288) | ||
103 | Hearing loss, complete | 0.300 (0.206–0.409) | 0.215 (0.144–0.307) | ||
104 | Hearing loss, mild, with ringing | 0.047 (0.029–0.069) | 0.021 (0.012–0.036) | Japan > GBD | |
105 | Hearing loss, moderate, with ringing | 0.119 (0.080–0.166) | 0.031 (0.019–0.049) | Japan > GBD | Japan > GBD |
106 | Hearing loss, severe, with ringing | 0.280 (0.193–0.386) | 0.261 (0.175–0.360) | ||
107 | Hearing loss, profound, with ringing | 0.307 (0.214–0.414) | 0.277 (0.182–0.387) | ||
108 | Hearing loss, complete, with ringing | 0.379 (0.266–0.514) | 0.316 (0.212–0.435) | ||
109 | Distance vision, mild impairment | 0.005 (0.002–0.012) | 0.003 (0.001–0.007) | ||
110 | Distance vision, moderate impairment | 0.051 (0.032–0.074) | 0.031 (0.019–0.049) | ||
111 | Distance vision, severe impairment | 0.378 (0.266–0.514) | 0.184 (0.124–0.260) | Japan > GBD | |
112 | Distance vision blindness | 0.427 (0.299–0.570) | 0.187 (0.124–0.260) | Japan > GBD | |
113 | Near vision impairment | 0.012 (0.006–0.023) | 0.011 (0.005–0.020) | ||
Musculoskeletal disorders | |||||
114 | Low back pain, mild | 0.028 (0.016–0.045) | 0.020 (0.011–0.035) | ||
115 | Low back pain, moderate | 0.069 (0.044–0.100) | 0.054 (0.035–0.079) | ||
116 | Back pain, severe, without leg pain | 0.190 (0.132–0.263) | 0.272 (0.182–0.373) | ||
117 | Back pain, severe, with leg pain | 0.276 (0.190–0.381) | 0.325 (0.219–0.446) | ||
118 | Back pain, most severe, without leg pain | 0.200 (0.141–0.274) | 0.367 (0.227–0.523) | ||
119 | Back pain, most severe, with leg pain | 0.276 (0.186–0.379) | 0.379 (0.236–0.540) | ||
120 | Neck pain, mild | 0.039 (0.023–0.058) | 0.053 (0.034–0.078) | ||
121 | Neck pain, moderate | 0.063 (0.041–0.091) | 0.114 (0.075–0.162) | ||
122 | Neck pain, severe | 0.169 (0.115–0.236) | 0.229 (0.153–0.317) | ||
123 | Neck pain, most severe | 0.144 (0.099–0.200) | 0.304 (0.202–0.415) | Japan < GBD | |
124 | Musculoskeletal problems, lower limbs, mild | 0.091 (0.060–0.129) | 0.023 (0.013–0.037) | Japan > GBD | Japan > GBD |
125 | Musculoskeletal problems, lower limbs, moderate | 0.142 (0.098–0.196) | 0.079 (0.054–0.110) | ||
126 | Musculoskeletal problems, lower limbs, severe | 0.327 (0.223–0.438) | 0.165 (0.112–0.232) | ||
127 | Musculoskeletal problems, upper limbs, mild | 0.039 (0.023–0.058) | 0.028 (0.017–0.045) | ||
128 | Musculoskeletal problems, upper limbs, moderate | 0.223 (0.153–0.307) | 0.117 (0.080–0.163) | ||
129 | Musculoskeletal problems, generalized, moderate | 0.255 (0.177–0.352) | 0.317 (0.216–0.440) | ||
130 | Musculoskeletal problems, generalized, severe | 0.420 (0.293–0.560) | 0.581 (0.403–0.739) | ||
131 | Grout: Acute | 0.322 (0.221–0.436) | 0.295 (0.196–0.409) | ||
Injury | |||||
132 | Amputation of finger(s), excluding thumb | 0.063 (0.041–0.092) | 0.005 (0.002–0.010) | Japan > GBD | Japan > GBD |
133 | Amputation of thumb (long term) | 0.093 (0.061–0.132) | 0.011 (0.005–0.021) | Japan > GBD | Japan > GBD |
134 | Amputation of one upper limb (with treatment) | 0.144 (0.096–0.205) | 0.039 (0.024–0.059) | Japan > GBD | Japan > GBD |
135 | Amputation of one upper limb (long term, without treatment) | 0.261 (0.182–0.357) | 0.118 (0.079–0.167) | Japan > GBD | |
136 | Amputation of both upper limbs (long term, with treatment) | 0.193 (0.132–0.274) | 0.123 (0.081–0.176) | ||
137 | Amputation of both upper limbs (long term, without treatment) | 0.422 (0.295–0.562) | 0.383 (0.251–0.525) | ||
138 | Amputation of toe | 0.080 (0.052–0.114) | 0.006 (0.002–0.012) | Japan > GBD | Japan > GBD |
139 | Amputation of one lower limb (long term, with treatment) | 0.096 (0.062–0.140) | 0.039 (0.023–0.059) | Japan > GBD | |
140 | Amputation of one lower limb (long term, without treatment) | 0.233 (0.162–0.318) | 0.173 (0.118–0.240) | ||
141 | Amputation of both lower limbs (long term, with treatment) | 0.146 (0.101–0.203) | 0.088 (0.057–0.124) | ||
142 | Amputation of both lower limbs (long term, without treatment) | 0.525 (0.377–0.681) | 0.443 (0.297–0.589) | ||
143 | Burns, <20% total burned surface area or < 10% total burned surface area if head/neck or hands/wrist involved (long term, with or without treatment) | 0.018 (0.009–0.031) | 0.016 (0.008–0.032) | ||
144 | Burns, ≥20% total burned surface area (short term, with or without treatment) | 0.208 (0.140–0.302) | 0.314 (0.211–0.441) | ||
145 | Burns, ≥20% total burned surface area or ≥10% total burned surface area if head/neck or hands/wrist involved (long term, with treatment) | 0.126 (0.085–0.176) | 0.135 (0.092–0.190) | ||
146 | Burns, ≥20% total burned surface area or ≥10% total burned surface area if head/neck or hands/wrist involved (long term, without treatment) | 0.396 (0.274–0.534) | 0.455 (0.302–0.601) | ||
147 | Crush injury (short or long term, with or without treatment) | 0.185 (0.129–0.257) | 0.132 (0.089–0.189) | ||
148 | Dislocation of hip (long term, with or without treatment) | 0.035 (0.021–0.053) | 0.016 (0.008–0.028) | Japan > GBD | |
149 | Dislocation of knee (long term, with or without treatment) | 0.252 (0.174–0.347) | 0.113 (0.075–0.160) | Japan > GBD | |
150 | Dislocation of shoulder (long term, with or without treatment) | 0.132 (0.091–0.187) | 0.062 (0.041–0.088) | Japan > GBD | |
151 | Other injuries of muscle and tendon (includes sprains, strains and dislocations other than shoulder, knee, hip) | 0.032 (0.018–0.049) | 0.008 (0.003–0.015) | Japan > GBD | Japan > GBD |
152 | Drowning and nonfatal submersion (short or long term, with or without treatment) | 0.079 (0.052–0.114) | 0.247 (0.164–0.341) | Japan < GBD | Japan < GBD |
153 | Fracture of clavicle, scapula or humerus (short or long term, with or without treatment) | 0.159 (0.106–0.222) | 0.035 (0.021–0.053) | Japan > GBD | Japan > GBD |
154 | Fracture of face bone (short or long term with or without treatment) | 0.184 (0.128–0.259) | 0.067 (0.044–0.097) | Japan > GBD | |
155 | Fracture of foot bones (short term, with or without treatment) | 0.094 (0.062–0.132) | 0.026 (0.015–0.043) | Japan > GBD | Japan > GBD |
156 | Fracture of foot bones (long term, without treatment) | 0.045 (0.027–0.066) | 0.026 (0.015–0.042) | ||
157 | Fracture of hand (short term, with or without treatment) | 0.041 (0.025–0.062) | 0.010 (0.005–0.019) | Japan > GBD | Japan > GBD |
158 | Fracture of hand (long term, without treatment) | 0.037 (0.022–0.058) | 0.014 (0.007–0.025) | Japan > GBD | |
159 | Fracture of neck of femur (short term, with or without treatment) | 0.321 (0.218–0.437) | 0.258 (0.172–0.356) | ||
160 | Fracture of neck of femur (long term, with treatment) | 0.120 (0.079–0.168) | 0.058 (0.038–0.084) | Japan > GBD | |
161 | Fracture of neck of femur (long term, without treatment) | 0.375 (0.260–0.502) | 0.402 (0.269–0.541) | ||
162 | Fracture, other than femoral neck (short term, with or without treatment) | 0.233 (0.159–0.324) | 0.111 (0.074–0.156) | Japan > GBD | |
163 | Fracture, other than femoral neck (long term, without treatment) | 0.079 (0.052–0.113) | 0.042 (0.027–0.063) | ||
164 | Fracture of patella, tibia or fibula or ankle (short term, with or without treatment) | 0.213 (0.143–0.294) | 0.050 (0.032–0.075) | Japan > GBD | Japan > GBD |
165 | Fracture of patella, tibia or fibula or ankle (long term, with or without treatment) | 0.122 (0.083–0.170) | 0.055 (0.036–0.081) | Japan > GBD | |
166 | Fracture of pelvis (short term) | 0.431 (0.296–0.577) | 0.279 (0.188–0.384) | ||
167 | Fracture of pelvis (long term) | 0.143 (0.098–0.204) | 0.182 (0.123–0.253) | ||
168 | Fracture of radius or ulna (short term, with or without treatment) | 0.081 (0.054–0.118) | 0.028 (0.016–0.046) | Japan > GBD | |
169 | Fracture of radius or ulna (long term, without treatment) | 0.079 (0.052–0.111) | 0.043 (0.028–0.064) | ||
170 | Fracture of skull (short or long term, with or without treatment) | 0.132 (0.087–0.190) | 0.071 (0.048–0.100) | ||
171 | Fracture of sternum and/or fracture of one or two ribs (short term, with or without treatment) | 0.170 (0.116–0.238) | 0.103 (0.068–0.145) | ||
172 | Fracture of vertebral column (short or long term, with or without treatment) | 0.106 (0.070–0.147) | 0.111 (0.075–0.156) | ||
173 | Fractures, treated (long term) | 0.008 (0.003–0.017) | 0.005 (0.002–0.014) | ||
174 | Injured nerves (short term) | 0.237 (0.157–0.329) | 0.100 (0.067–0.140) | Japan > GBD | |
175 | Injured nerves (long term) | 0.161 (0.111–0.223) | 0.113 (0.076–0.157) | ||
176 | Injury to eyes (short term) | 0.076 (0.049–0.109) | 0.054 (0.035–0.081) | ||
177 | Concussion | 0.170 (0.112–0.244) | 0.110 (0.074–0.158) | ||
178 | Severe traumatic brain injury, short term (with or without treatment) | 0.114 (0.075–0.162) | 0.214 (0.141–0.297) | ||
179 | Traumatic brain injury, long-term consequences, minor (with or without treatment) | 0.192 (0.132–0.266) | 0.094 (0.063–0.133) | Japan > GBD | |
180 | Traumatic brain injury, long-term consequences, moderate (with or without treatment) | 0.212 (0.144–0.299) | 0.231 (0.156–0.324) | ||
181 | Traumatic brain injury, long-term consequences, severe (with or without treatment) | 0.455 (0.315–0.600) | 0.637 (0.462–0.789) | ||
182 | Open wound (short term, with or without treatment) | 0.035 (0.021–0.055) | 0.006 (0.002–0.012) | Japan > GBD | Japan > GBD |
183 | Poisoning (short term with or without treatment) | 0.276 (0.193–0.377) | 0.163 (0.109–0.227) | ||
184 | Severe chest injury (long term, with or without treatment) | 0.065 (0.042–0.095) | 0.047 (0.030–0.070) | ||
185 | Severe chest injury (short term, with or without treatment) | 0.220 (0.152–0.306) | 0.369 (0.248–0.501) | ||
186 | Spinal cord lesion below neck level (treated) | 0.388 (0.270–0.524) | 0.296 (0.198–0.414) | ||
187 | Spinal cord lesion below neck level (untreated) | 0.564 (0.404–0.722) | 0.623 (0.434–0.777) | ||
188 | Spinal cord lesion at neck level (treated) | 0.637 (0.468–0.792) | 0.589 (0.415–0.748) | ||
189 | Spinal cord lesion at neck level (untreated) | 0.707 (0.527–0.842) | 0.732 (0.544–0.871) | ||
Other | |||||
190 | Abdominopelvic problem, mild | 0.029 (0.016–0.046) | 0.011 (0.005–0.021) | Japan > GBD | |
191 | Abdominopelvic problem, moderate | 0.392 (0.270–0.524) | 0.114 (0.078–0.159) | Japan > GBD | Japan > GBD |
192 | Abdominopelvic problem, severe | 0.339 (0.235–0.458) | 0.324 (0.220–0.442) | ||
193 | Anemia, mild | 0.004 (0.001–0.009) | 0.004 (0.001–0.008) | ||
194 | Anemia, moderate | 0.064 (0.040–0.092) | 0.052 (0.034–0.076) | ||
195 | Anemia, severe | 0.040 (0.024–0.061) | 0.149 (0.101–0.209) | Japan < GBD | Japan < GBD |
196 | Periodontitis | 0.008 (0.003–0.015) | 0.007 (0.003–0.014) | ||
197 | Dental caries: symptomatic | 0.035 (0.021–0.053) | 0.010 (0.005–0.019) | Japan > GBD | Japan > GBD |
198 | Severe tooth loss | 0.082 (0.053–0.115) | 0.067 (0.045–0.095) | ||
199 | Disfigurement: level 1 | 0.043 (0.026–0.063) | 0.011 (0.005–0.021) | Japan > GBD | Japan > GBD |
200 | Disfigurement: level 2 | 0.123 (0.083–0.171) | 0.067 (0.044–0.096) | ||
201 | Disfigurement: level 3 | 0.512 (0.362–0.670) | 0.405 (0.275–0.546) | ||
202 | Generic uncomplicated disease: worry and daily medication | 0.016 (0.008–0.028) | 0.049 (0.031–0.072) | Japan < GBD | Japan < GBD |
203 | Generic uncomplicated disease: anxiety about diagnosis | 0.008 (0.003–0.015) | 0.012 (0.006–0.023) | ||
204 | Severe wasting | 0.086 (0.056–0.124) | 0.128 (0.082–0.183) | ||
205 | Speech problems | 0.065 (0.041–0.094) | 0.051 (0.032–0.078) | ||
206 | Motor impairment, mild | 0.009 (0.004–0.016) | 0.010 (0.005–0.019) | ||
207 | Motor impairment, moderate | 0.045 (0.028–0.065) | 0.061 (0.040–0.089) | ||
208 | Motor impairment, severe | 0.294 (0.202–0.396) | 0.402 (0.268–0.545) | ||
209 | Motor plus cognitive impairments, mild | 0.023 (0.013–0.038) | 0.031 (0.018–0.050) | ||
210 | Motor plus cognitive impairments, moderate | 0.106 (0.069–0.150) | 0.203 (0.134–0.290) | ||
211 | Motor plus cognitive impairments, severe | 0.457 (0.318–0.606) | 0.542 (0.374–0.702) | ||
212 | Thrombocytopenic purpura | 0.110 (0.073–0.154) | 0.159 (0.106–0.226) | ||
213 | Hypothyroidism | 0.012 (0.005–0.023) | 0.019 (0.010–0.032) | ||
214 | Hyperthyroidism | 0.103 (0.069–0.146) | 0.145 (0.096–0.202) | ||
215 | Vertigo and balance disorder (Menière, labyrinthitis) | 0.102 (0.069–0.145) | 0.113 (0.074–0.158) | ||
216 | Allergic rhinitis (hay fever) | 0.009 (0.004–0.016) | 0.007 (0.003–0.017) | ||
217 | Borderline personality disorder | 0.132 (0.091–0.186) | 0.190 (0.120–0.262) | ||
218 | Carpal tunnel syndrome | 0.020 (0.011–0.034) | 0.035 (0.023–0.055) | ||
219 | Constipation | 0.048 (0.030–0.070) | 0.061 (0.040–0.093) | ||
220 | Hemorrhoids | 0.090 (0.058–0.127) | 0.109 (0.072–0.154) | ||
221 | Heart burn and reflux “GERD” | 0.046 (0.029–0.069) | 0.027 (0.015–0.046) | ||
222 | Insomnia | 0.036 (0.022–0.055) | 0.016 (0.009–0.031) | Japan > GBD | |
223 | Intensive care unit admission | 0.675 (0.506–0.822) | 0.739 (0.526–0.891) | ||
224 | Invasive device/drain | 0.512 (0.362–0.664) | 0.143 (0.095–0.207) | Japan > GBD | Japan > GBD |
225 | Irritable bowel syndrome | 0.039 (0.024–0.059) | 0.064 (0.040–0.093) | ||
226 | Sleep apnea | 0.024 (0.014–0.040) | 0.032 (0.020–0.051) | ||
227 | Somatoform disorder | 0.060 (0.038–0.086) | 0.140 (0.095–0.199) | Japan < GBD | |
228 | Varicose veins | 0.018 (0.010–0.031) | 0.020 (0.010–0.037) | ||
229 | Trigeminal neuralgia | 0.128 (0.086–0.181) | 0.068 (0.045–0.101) | ||
230 | Vaginal discharge | 0.096 (0.062–0.135) | NA | ||
231 | Dermatitis | 0.079 (0.050–0.115) | NA |